Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02605733 · ClinicalTrials.gov registry record
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
A clinical trial, sponsored by Sharp HealthCare.
- Completed
- Registry status
- 130
- Enrollment target
NCT02605733: Completed study, sponsored by Sharp HealthCare.
NCT02605733 is a clinical trial that has completed, run by Sharp HealthCare. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02605733 has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the normal brain function of premature infants (23 to 31+6 weeks GA) during birth transition and through the first 72 hours of life.
Primary Outcome
amplitude integrated EEG to measure brain activity
Interventions
- DEVICE EEG
- DEVICE NIRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2015-10 |
| Est. Completion | 2021-05-13 |
What the finished NCT02605733 record still lists
NCT02605733 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which EEG is the first listed.
NCT02605733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02605733 about?
NCT02605733 is a clinical study titled "The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation". The purpose of this study is to characterize the normal brain function of premature infants (23 to 31+6 weeks GA) during birth transition and through the first 72 hours of life.
What is the current status of trial NCT02605733?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2015-10. Estimated completion is 2021-05-13.
What interventions are being tested in trial NCT02605733?
The interventions under investigation include: EEG (DEVICE), NIRS (DEVICE).
Who is sponsoring clinical trial NCT02605733?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia